TP53 and cancer: Taken together with the blinded whole-slide pathologic evaluation of TP53 wild-type vs. mutated samples, these findings show that our model consistently reproduces typical histologic features of TP53 mutant cancers, specifically increased inflammation and mitotic activity, together with their proteomic and transcriptomic signatures.